Lv1
30 积分 2024-03-06 加入
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
22小时前
待确认
Philadelphia-chromosome positive acute lymphoblastic leukemia: ten frequently asked questions
2个月前
已完结
Enasidenib in relapsed aggressive systemic mastocytosis with IDH2 mutation
2个月前
已完结
HA-1-targeted T cell receptor (TCR) T cell therapy for recurrent leukemia after hematopoietic stem cell transplantation
2个月前
已完结
第5版WHO造血与淋巴组织肿瘤分类组织细胞/树突细胞肿瘤及淋巴组织间质源性肿瘤解读
4个月前
已完结
Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?
4个月前
已完结
Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study
5个月前
已完结
Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial
5个月前
已完结
Asciminib Monotherapy as Frontline Treatment of Chronic-Phase Chronic Myeloid Leukemia: Results from the ASCEND Study
5个月前
已关闭
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
5个月前
已完结
皖公网安备34019202002308
